Familial Mediterranean fever and MEFV gene variants in hidradenitis suppurativa: A systematic review
Katherine Aw
Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
Search for more papers by this authorHillary A. Chan
Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
Search for more papers by this authorCathryn Sibbald
Department of Paediatrics, Dermatology, The Hospital for Sick Children, Toronto, Ontario, Canada
Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada
Search for more papers by this authorVincent Piguet
Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada
Search for more papers by this authorCorresponding Author
David Croitoru
Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada
Division of Dermatology, University Health Network, Toronto, Ontario, Canada
Correspondence
David Croitoru, Division of Dermatology, Department of Medicine, Women's College Hospital, Floor 5, 76 Grenville Street, Toronto, ON M5S 1B2, Canada.
Email: [email protected]
Search for more papers by this authorKatherine Aw
Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
Search for more papers by this authorHillary A. Chan
Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
Search for more papers by this authorCathryn Sibbald
Department of Paediatrics, Dermatology, The Hospital for Sick Children, Toronto, Ontario, Canada
Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada
Search for more papers by this authorVincent Piguet
Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada
Search for more papers by this authorCorresponding Author
David Croitoru
Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada
Division of Dermatology, University Health Network, Toronto, Ontario, Canada
Correspondence
David Croitoru, Division of Dermatology, Department of Medicine, Women's College Hospital, Floor 5, 76 Grenville Street, Toronto, ON M5S 1B2, Canada.
Email: [email protected]
Search for more papers by this author
Open Research
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available from the corresponding author upon reasonable request.
REFERENCES
- 1Vural S, Gundogdu M, Gokpinar Ili E, Durmaz CD, Vural A, Steinmuller-Magin L, et al. Association of pyrin mutations and autoinflammation with complex phenotype hidradenitis suppurativa: a case-control study. Br J Dermatol. 2019; 180(6): 1459–1467.
- 2Lancieri M, Bustaffa M, Palmeri S, Prigione I, Penco F, Papa R, et al. An update on familial Mediterranean fever. Int J Mol Sci. 2023; 24(11):9584.
- 3Marzano AV, Damiani G, Ceccherini I, Berti E, Gattorno M, Cugno M. Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis). Br J Dermatol. 2017; 176(6): 1588–1598.
- 4Hodak E, Atzmony L, Pavlovsky L, Comaneshter D, Cohen AD. Hidradenitis suppurativa is associated with familial Mediterranean fever-a population-based study. J Invest Dermatol. 2017; 137(9): 2019–2021.
- 5Oktem A, Rasulova G, Cavdarli B, Bostanci S, Heper A, Vural S. Successful treatment with anakinra in generalized spiculated porokeratosis and severe hidradenitis suppurativa in a patient with MVK and MEFV mutations. Clin Exp Dermatol. 2023; 48(2): 161–165.
- 6Leslie KS, Tripathi SV, Nguyen TV, Pauli M, Rosenblum MD. An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa. J Am Acad Dermatol. 2014; 70(2): 243–251.
- 7Tzanetakou V, Kanni T, Giatrakou S, Katoulis A, Papadavid E, Netea MG, et al. Safety and efficacy of anakinra in severe hidradenitis suppurativa: a randomized clinical trial. JAMA Dermatol. 2016; 152(1): 52–59.
- 8André R, Marescassier H, Gabay C, Pittet B, Laffitte E. Long-term therapy with anakinra in hidradenitis suppurativa in three patients. Int J Dermatol. 2019; 58(11): e208–e209.
- 9Suntres E, Manzar D, Alhusayen R. Safety and efficacy of interleukin-1β inhibitors for hidradenitis suppurativa: a systematic review. J Cutan Med Surg. 2024; 28(2): 203–204.
